Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunocore Holdings Ltd

IMCR
Current price
30.16 USD -0.44 USD (-1.44%)
Last closed 29.80 USD
ISIN US45258D1054
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 498 132 480 USD
Yield for 12 month -48.09 %
1Y
3Y
5Y
10Y
15Y
IMCR
21.11.2021 - 28.11.2021

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 3 clinical trial to treat advanced cutaneous melanoma and adjuvant uveal melanoma; and brenetafusp that is in Phase 3 clinical trial to treat first-line advanced cutaneous melanoma and in a Phase 1/2 clinical trial in multiple tumor types. In addition, the company's products under development include IMC-R117C (PIWIL-1) that is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, including colorectal cancer; IMC-P115C (PRAME-HLE-A02) that is in Phase 1 clinical trial for patients with tumors that express PRAME; IMC-M113V that is in Phase 1 clinical trials for a potential functional cure in human immunodeficiency virus (HIV); and IMC-I109V that is in Phase 1 clinical trials for a potential functional cure in hepatitis B virus (HBV). Further, it develops IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-S118AI to treat type 1 diabetes; and IMC-U120AI to treat atopic dermatitis. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom. Address: 92 Park Drive, Abingdon, United Kingdom, OX14 4RY

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

62.75 USD

P/E ratio

Dividend Yield

Current Year

+310 202 000 USD

Last Year

+249 428 000 USD

Current Quarter

+84 052 000 USD

Last Quarter

+80 248 000 USD

Current Year

+307 471 000 USD

Last Year

+248 391 000 USD

Current Quarter

+83 722 000 USD

Last Quarter

+79 800 000 USD

Key Figures IMCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -48 206 000 USD
Operating Margin TTM -1.67 %
Price to Earnings
Return On Assets TTM -4.08 %
PEG Ratio
Return On Equity TTM -14.01 %
Wall Street Target Price 62.75 USD
Revenue TTM 310 201 984 USD
Book Value 7.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 19.80 %
Dividend Yield
Gross Profit TTM 299 700 000 USD
Earnings per share -1.02 USD
Diluted Eps TTM -1.02 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 822.00 %
Profit Margin -16.47 %

Dividend Analytics IMCR

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History IMCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio TTM
Last Split Date

Stock Valuation IMCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.58
Price Sales TTM 4.83
Enterprise Value EBITDA -45.82
Price Book MRQ 4.15

Financials IMCR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMCR

For 52 weeks

23.15 USD 62.74 USD
50 Day MA 28.95 USD
Shares Short Prior Month 7 587 433
200 Day MA 32.21 USD
Short Ratio 22.49
Shares Short 8 076 037
Short Percent 22.73 %